Share Price and Basic Stock Data
Last Updated: April 2, 2025, 8:35 pm
| PEG Ratio | 0.00 |
|---|
Competitors of Bilcare Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 157 Cr. | 151 | 239/132 | 13.2 | 201 | 0.79 % | 11.1 % | 8.65 % | 10.0 |
| Gujarat Containers Ltd | 98.9 Cr. | 175 | 200/142 | 11.5 | 83.6 | 0.86 % | 22.7 % | 22.9 % | 10.0 |
| Goblin India Ltd | 30.7 Cr. | 22.2 | 60.0/18.8 | 7.94 | 31.8 | 0.00 % | 8.18 % | 6.90 % | 10.0 |
| G K P Printing & Packaging Ltd | 13.1 Cr. | 5.96 | 12.0/4.85 | 9.98 | 0.00 % | 5.50 % | 7.89 % | 10.0 | |
| Garware Hi Tech Films Ltd | 8,747 Cr. | 3,770 | 5,378/1,513 | 28.1 | 960 | 0.27 % | 14.0 % | 10.4 % | 10.0 |
| Industry Average | 2,195.46 Cr | 339.87 | 76.80 | 174.00 | 0.32% | 11.89% | 34.68% | 7.38 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 208 | 256 | 248 | 254 | 246 | 234 | 182 | 190 | 175 | 200 | 194 | 202 | 198 |
| Expenses | 194 | 237 | 232 | 240 | 234 | 219 | 169 | 173 | 158 | 208 | 175 | 194 | 187 |
| Operating Profit | 13 | 19 | 16 | 14 | 12 | 14 | 13 | 17 | 17 | -8 | 19 | 8 | 11 |
| OPM % | 6% | 7% | 6% | 6% | 5% | 6% | 7% | 9% | 10% | -4% | 10% | 4% | 5% |
| Other Income | 0 | 5 | 3 | 10 | -6 | 231 | 3 | 1 | 4 | 9 | 4 | -6 | -6 |
| Interest | 16 | 17 | 16 | 16 | 16 | 11 | 19 | 20 | 21 | 23 | 21 | 24 | 19 |
| Depreciation | 10 | 9 | 9 | 9 | 10 | 9 | 10 | 10 | 11 | 13 | 12 | 11 | 12 |
| Profit before tax | -12 | -3 | -7 | -2 | -20 | 225 | -13 | -13 | -10 | -35 | -10 | -33 | -27 |
| Tax % | -2% | 38% | -11% | 60% | -6% | 65% | -1% | -5% | 34% | -44% | 55% | -10% | -40% |
| Net Profit | -11 | -3 | -6 | -3 | -19 | 78 | -13 | -12 | -14 | -20 | -15 | -30 | -16 |
| EPS in Rs | -5.90 | -2.48 | -2.84 | -2.42 | -7.98 | 19.63 | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.05 |
Last Updated: February 28, 2025, 12:56 pm
Below is a detailed analysis of the quarterly data for Bilcare Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹198.00 Cr.. The value appears to be declining and may need further review. It has decreased from 202.00 Cr. (Sep 2024) to ₹198.00 Cr., marking a decrease of 4.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹187.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 194.00 Cr. (Sep 2024) to ₹187.00 Cr., marking a decrease of 7.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Sep 2024) to ₹11.00 Cr., marking an increase of 3.00 Cr..
- For OPM %, as of Dec 2024, the value is 5.00%. The value appears strong and on an upward trend. It has increased from 4.00% (Sep 2024) to 5.00%, marking an increase of 1.00%.
- For Other Income, as of Dec 2024, the value is ₹-6.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded -6.00 Cr..
- For Interest, as of Dec 2024, the value is ₹19.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 24.00 Cr. (Sep 2024) to ₹19.00 Cr., marking a decrease of 5.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Sep 2024) to ₹12.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹-27.00 Cr.. The value appears strong and on an upward trend. It has increased from -33.00 Cr. (Sep 2024) to ₹-27.00 Cr., marking an increase of 6.00 Cr..
- For Tax %, as of Dec 2024, the value is -40.00%. The value appears to be improving (decreasing) as expected. It has decreased from -10.00% (Sep 2024) to -40.00%, marking a decrease of 30.00%.
- For Net Profit, as of Dec 2024, the value is ₹-16.00 Cr.. The value appears strong and on an upward trend. It has increased from -30.00 Cr. (Sep 2024) to ₹-16.00 Cr., marking an increase of 14.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is -3.05. The value appears strong and on an upward trend. It has increased from -6.81 (Sep 2024) to -3.05, marking an increase of 3.76.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 1:46 pm
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,547 | 3,062 | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 794 |
| Expenses | 3,159 | 2,819 | 2,506 | 2,396 | 2,443 | 2,617 | 2,827 | 1,782 | 572 | 784 | 925 | 708 | 765 |
| Operating Profit | 387 | 243 | 186 | 207 | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 29 |
| OPM % | 11% | 8% | 7% | 8% | 7% | 6% | 6% | 2% | 8% | 7% | 6% | 5% | 4% |
| Other Income | -8 | 24 | 9 | -87 | 107 | 297 | 59 | 254 | 45 | 44 | 237 | 16 | 0 |
| Interest | 167 | 217 | 236 | 151 | 176 | 249 | 283 | 174 | 76 | 69 | 60 | 82 | 87 |
| Depreciation | 148 | 141 | 191 | 164 | 177 | 416 | 378 | 239 | 46 | 39 | 38 | 45 | 48 |
| Profit before tax | 63 | -91 | -232 | -194 | -56 | -207 | -433 | -114 | -25 | -4 | 196 | -72 | -105 |
| Tax % | 30% | 25% | -7% | -58% | 42% | -4% | 5% | -13% | -55% | 3% | 74% | -18% | |
| Net Profit | 44 | -114 | -216 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -81 |
| EPS in Rs | 16.81 | -48.14 | -91.76 | -36.04 | -35.91 | -85.43 | -193.28 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -17.20 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -359.09% | -89.47% | 62.04% | 2.44% | -148.75% | -127.64% | 78.15% | 88.89% | 63.64% | 1350.00% | -218.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 269.62% | 151.51% | -59.60% | -151.19% | 21.11% | 205.78% | 10.74% | -25.25% | 1286.36% | -1568.00% |
Bilcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -24% |
| 3 Years: | 6% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 14% |
| 3 Years: | 0% |
| TTM: | -98% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 43% |
| 3 Years: | 7% |
| 1 Year: | 47% |
| Return on Equity | |
|---|---|
| 10 Years: | -35% |
| 5 Years: | -40% |
| 3 Years: | -9% |
| Last Year: | -6% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 5:41 pm
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 1,302 | 1,300 | 1,073 | 689 | 590 | 376 | -93 | 85 | 63 | 52 | 507 | 474 | 452 |
| Borrowings | 2,104 | 2,146 | 2,311 | 2,122 | 2,014 | 2,089 | 2,270 | 707 | 677 | 690 | 639 | 756 | 739 |
| Other Liabilities | 971 | 899 | 933 | 786 | 830 | 913 | 888 | 297 | 300 | 362 | 424 | 314 | 329 |
| Total Liabilities | 4,400 | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,543 |
| Fixed Assets | 1,493 | 2,126 | 1,926 | 2,432 | 2,403 | 2,180 | 2,005 | 534 | 494 | 465 | 1,045 | 1,038 | 971 |
| CWIP | 846 | 262 | 218 | 161 | 149 | 170 | 79 | 0 | 0 | 1 | 1 | 1 | 1 |
| Investments | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 8 | 12 |
| Other Assets | 2,061 | 1,979 | 2,196 | 1,026 | 904 | 1,051 | 1,003 | 577 | 570 | 661 | 545 | 521 | 559 |
| Total Assets | 4,400 | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,543 |
Below is a detailed analysis of the balance sheet data for Bilcare Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 24.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹452.00 Cr.. The value appears to be declining and may need further review. It has decreased from 474.00 Cr. (Mar 2024) to ₹452.00 Cr., marking a decrease of 22.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹739.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 756.00 Cr. (Mar 2024) to ₹739.00 Cr., marking a decrease of 17.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹329.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 314.00 Cr. (Mar 2024) to ₹329.00 Cr., marking an increase of 15.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹1,543.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,568.00 Cr. (Mar 2024) to ₹1,543.00 Cr., marking a decrease of 25.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹971.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,038.00 Cr. (Mar 2024) to ₹971.00 Cr., marking a decrease of 67.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Investments, as of Sep 2024, the value is ₹12.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to ₹12.00 Cr., marking an increase of 4.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹559.00 Cr.. The value appears strong and on an upward trend. It has increased from 521.00 Cr. (Mar 2024) to ₹559.00 Cr., marking an increase of 38.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹1,543.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,568.00 Cr. (Mar 2024) to ₹1,543.00 Cr., marking a decrease of 25.00 Cr..
However, the Borrowings (739.00 Cr.) are higher than the Reserves (₹452.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 385.00 | 241.00 | 184.00 | 205.00 | 188.00 | 159.00 | 168.00 | -662.00 | -626.00 | -630.00 | -582.00 | -717.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106 | 105 | 125 | 35 | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 |
| Inventory Days | 80 | 103 | 105 | 108 | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 |
| Days Payable | 90 | 76 | 93 | 86 | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 |
| Cash Conversion Cycle | 95 | 132 | 137 | 57 | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 |
| Working Capital Days | 130 | 145 | 156 | 35 | 16 | 24 | 28 | 27 | 67 | 57 | 36 | 115 |
| ROCE % | 8% | 3% | 1% | 2% | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% |
This stock is not held by any mutual fund
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -14.12 | 6.39 | -5.35 | -8.95 | -43.97 |
| Diluted EPS (Rs.) | -14.12 | 6.39 | -5.35 | -8.95 | -43.97 |
| Cash EPS (Rs.) | -5.77 | 37.38 | 14.82 | 14.59 | 59.36 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 274.44 | 161.27 | 68.51 | 69.74 | 74.82 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 274.44 | 298.99 | 68.51 | 69.74 | 74.82 |
| Revenue From Operations / Share (Rs.) | 317.34 | 416.87 | 358.76 | 264.48 | 775.96 |
| PBDIT / Share (Rs.) | 26.19 | 28.45 | 31.86 | 29.45 | 60.44 |
| PBIT / Share (Rs.) | 7.10 | 12.39 | 15.18 | 10.12 | -40.98 |
| PBT / Share (Rs.) | -30.45 | 83.28 | -1.79 | -10.60 | -48.27 |
| Net Profit / Share (Rs.) | -24.86 | 21.32 | -1.85 | -4.74 | -42.06 |
| NP After MI And SOA / Share (Rs.) | -14.12 | 6.39 | -5.35 | -8.95 | -43.97 |
| PBDIT Margin (%) | 8.25 | 6.82 | 8.87 | 11.13 | 7.78 |
| PBIT Margin (%) | 2.23 | 2.97 | 4.23 | 3.82 | -5.28 |
| PBT Margin (%) | -9.59 | 19.97 | -0.50 | -4.00 | -6.22 |
| Net Profit Margin (%) | -7.83 | 5.11 | -0.51 | -1.79 | -5.42 |
| NP After MI And SOA Margin (%) | -4.44 | 1.53 | -1.49 | -3.38 | -5.66 |
| Return on Networth / Equity (%) | -6.67 | 7.29 | -16.75 | -24.42 | -95.60 |
| Return on Capital Employeed (%) | 1.37 | 2.32 | 4.93 | 3.17 | -12.05 |
| Return On Assets (%) | -2.12 | 0.94 | -1.11 | -1.98 | -9.31 |
| Long Term Debt / Equity (X) | 1.09 | 2.49 | 7.14 | 6.14 | 5.16 |
| Total Debt / Equity (X) | 1.52 | 3.09 | 9.18 | 7.85 | 6.53 |
| Asset Turnover Ratio (%) | 0.47 | 0.72 | 0.43 | 0.29 | 0.10 |
| Current Ratio (X) | 1.17 | 1.01 | 1.04 | 1.08 | 1.17 |
| Quick Ratio (X) | 0.87 | 0.76 | 0.70 | 0.75 | 0.92 |
| Inventory Turnover Ratio (X) | 5.47 | 6.44 | 3.73 | 3.31 | 0.74 |
| Interest Coverage Ratio (X) | 0.75 | 1.12 | 1.09 | 0.91 | 0.81 |
| Interest Coverage Ratio (Post Tax) (X) | 0.36 | -1.94 | 0.51 | 0.49 | -0.47 |
| Enterprise Value (Cr.) | 998.83 | 881.91 | 900.48 | 834.43 | 745.76 |
| EV / Net Operating Revenue (X) | 1.34 | 0.89 | 1.07 | 1.34 | 0.40 |
| EV / EBITDA (X) | 16.20 | 13.16 | 12.01 | 12.03 | 5.24 |
| MarketCap / Net Operating Revenue (X) | 0.17 | 0.10 | 0.19 | 0.21 | 0.01 |
| Price / BV (X) | 0.26 | 0.49 | 2.19 | 1.57 | 0.32 |
| Price / Net Operating Revenue (X) | 0.17 | 0.10 | 0.19 | 0.21 | 0.01 |
| EarningsYield | -0.25 | 0.14 | -0.07 | -0.15 | -2.93 |
After reviewing the key financial ratios for Bilcare Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is -14.12. This value is below the healthy minimum of 5. It has decreased from 6.39 (Mar 23) to -14.12, marking a decrease of 20.51.
- For Diluted EPS (Rs.), as of Mar 24, the value is -14.12. This value is below the healthy minimum of 5. It has decreased from 6.39 (Mar 23) to -14.12, marking a decrease of 20.51.
- For Cash EPS (Rs.), as of Mar 24, the value is -5.77. This value is below the healthy minimum of 3. It has decreased from 37.38 (Mar 23) to -5.77, marking a decrease of 43.15.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 274.44. It has increased from 161.27 (Mar 23) to 274.44, marking an increase of 113.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 274.44. It has decreased from 298.99 (Mar 23) to 274.44, marking a decrease of 24.55.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 317.34. It has decreased from 416.87 (Mar 23) to 317.34, marking a decrease of 99.53.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 26.19. This value is within the healthy range. It has decreased from 28.45 (Mar 23) to 26.19, marking a decrease of 2.26.
- For PBIT / Share (Rs.), as of Mar 24, the value is 7.10. This value is within the healthy range. It has decreased from 12.39 (Mar 23) to 7.10, marking a decrease of 5.29.
- For PBT / Share (Rs.), as of Mar 24, the value is -30.45. This value is below the healthy minimum of 0. It has decreased from 83.28 (Mar 23) to -30.45, marking a decrease of 113.73.
- For Net Profit / Share (Rs.), as of Mar 24, the value is -24.86. This value is below the healthy minimum of 2. It has decreased from 21.32 (Mar 23) to -24.86, marking a decrease of 46.18.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -14.12. This value is below the healthy minimum of 2. It has decreased from 6.39 (Mar 23) to -14.12, marking a decrease of 20.51.
- For PBDIT Margin (%), as of Mar 24, the value is 8.25. This value is below the healthy minimum of 10. It has increased from 6.82 (Mar 23) to 8.25, marking an increase of 1.43.
- For PBIT Margin (%), as of Mar 24, the value is 2.23. This value is below the healthy minimum of 10. It has decreased from 2.97 (Mar 23) to 2.23, marking a decrease of 0.74.
- For PBT Margin (%), as of Mar 24, the value is -9.59. This value is below the healthy minimum of 10. It has decreased from 19.97 (Mar 23) to -9.59, marking a decrease of 29.56.
- For Net Profit Margin (%), as of Mar 24, the value is -7.83. This value is below the healthy minimum of 5. It has decreased from 5.11 (Mar 23) to -7.83, marking a decrease of 12.94.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is -4.44. This value is below the healthy minimum of 8. It has decreased from 1.53 (Mar 23) to -4.44, marking a decrease of 5.97.
- For Return on Networth / Equity (%), as of Mar 24, the value is -6.67. This value is below the healthy minimum of 15. It has decreased from 7.29 (Mar 23) to -6.67, marking a decrease of 13.96.
- For Return on Capital Employeed (%), as of Mar 24, the value is 1.37. This value is below the healthy minimum of 10. It has decreased from 2.32 (Mar 23) to 1.37, marking a decrease of 0.95.
- For Return On Assets (%), as of Mar 24, the value is -2.12. This value is below the healthy minimum of 5. It has decreased from 0.94 (Mar 23) to -2.12, marking a decrease of 3.06.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 1.09. This value exceeds the healthy maximum of 1. It has decreased from 2.49 (Mar 23) to 1.09, marking a decrease of 1.40.
- For Total Debt / Equity (X), as of Mar 24, the value is 1.52. This value exceeds the healthy maximum of 1. It has decreased from 3.09 (Mar 23) to 1.52, marking a decrease of 1.57.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.47. It has decreased from 0.72 (Mar 23) to 0.47, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 24, the value is 1.17. This value is below the healthy minimum of 1.5. It has increased from 1.01 (Mar 23) to 1.17, marking an increase of 0.16.
- For Quick Ratio (X), as of Mar 24, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.76 (Mar 23) to 0.87, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.47. This value is within the healthy range. It has decreased from 6.44 (Mar 23) to 5.47, marking a decrease of 0.97.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 0.75. This value is below the healthy minimum of 3. It has decreased from 1.12 (Mar 23) to 0.75, marking a decrease of 0.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 0.36. This value is below the healthy minimum of 3. It has increased from -1.94 (Mar 23) to 0.36, marking an increase of 2.30.
- For Enterprise Value (Cr.), as of Mar 24, the value is 998.83. It has increased from 881.91 (Mar 23) to 998.83, marking an increase of 116.92.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.34. This value is within the healthy range. It has increased from 0.89 (Mar 23) to 1.34, marking an increase of 0.45.
- For EV / EBITDA (X), as of Mar 24, the value is 16.20. This value exceeds the healthy maximum of 15. It has increased from 13.16 (Mar 23) to 16.20, marking an increase of 3.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.17. This value is below the healthy minimum of 1. It has increased from 0.10 (Mar 23) to 0.17, marking an increase of 0.07.
- For Price / BV (X), as of Mar 24, the value is 0.26. This value is below the healthy minimum of 1. It has decreased from 0.49 (Mar 23) to 0.26, marking a decrease of 0.23.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.17. This value is below the healthy minimum of 1. It has increased from 0.10 (Mar 23) to 0.17, marking an increase of 0.07.
- For EarningsYield, as of Mar 24, the value is -0.25. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to -0.25, marking a decrease of 0.39.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bilcare Ltd:
- Net Profit Margin: -7.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.37% (Industry Average ROCE: 11.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -6.67% (Industry Average ROE: 34.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.36
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.87
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 76.8)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.52
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.83%
About the Company - Qualitative Analysis
Bilcare Ltd. is a Public Limited Listed company incorporated on 01/07/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L28939PN1987PLC043953 and registration number is 043953. Currently company belongs to the Industry of Packaging & Containers. Company's Total Operating Revenue is Rs. 17.60 Cr. and Equity Capital is Rs. 23.55 Cr. for the Year ended 31/03/2024.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 1028, Shiroli, Rajgurunagar, Pune Maharashtra 410505 | cs@bilcare.com http://www.bilcare.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shreyans Bhandari | Chairman & Managing Director |
| Mr. Rajesh Devene | Independent Director |
| Mrs. Madhuri Vaidya | Independent Director |
| Ms. Kavita Bhansali | Executive Director |
| Dr. Abhigyan Upadhyay | Non Exe.Non Ind.Director |
| Ms. Alka Sagar | Independent Director |
FAQ
What is the intrinsic value of Bilcare Ltd?
Bilcare Ltd's intrinsic value (as of 04 April 2025) is ₹156.76 — 71.89% higher the current market price of ₹91.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 215 Cr. market cap, FY2025-2026 high/low of ₹94.1/51.0, reserves of 452 Cr, and liabilities of 1,543 Cr.
What is the Market Cap of Bilcare Ltd?
The Market Cap of Bilcare Ltd is 215 Cr..
What is the current Stock Price of Bilcare Ltd as on 04 April 2025?
The current stock price of Bilcare Ltd as on 04 April 2025 is 91.2.
What is the High / Low of Bilcare Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bilcare Ltd stocks is ₹94.1/51.0.
What is the Stock P/E of Bilcare Ltd?
The Stock P/E of Bilcare Ltd is .
What is the Book Value of Bilcare Ltd?
The Book Value of Bilcare Ltd is 202.
What is the Dividend Yield of Bilcare Ltd?
The Dividend Yield of Bilcare Ltd is 0.00 %.
What is the ROCE of Bilcare Ltd?
The ROCE of Bilcare Ltd is 0.82 %.
What is the ROE of Bilcare Ltd?
The ROE of Bilcare Ltd is 6.34 %.
What is the Face Value of Bilcare Ltd?
The Face Value of Bilcare Ltd is 10.0.